About
Gene Therapy
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide TherapyBoston & New England
Team (11)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
12,024
By Phase
PHASE1/PHASE2: 1
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT04833907Lead Sponsor
rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease
PHASE1/PHASE2Recruiting
24 participants
Started: Apr 1, 2021 · Completed: Aug 31, 2027
NCT03047369Collaborator
The Myelin Disorders Biorepository Project
N/ARecruiting
12,000 participants
Started: Dec 8, 2016 · Completed: Dec 8, 2030
Locations (1)
Headquarters
Wakefield, MA, United States
Map
Loading map...